Has Lowell Weil, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $2,245,843 in general payments to Lowell Weil, DPM across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lowell Weil, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lowell Weil, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lowell Weil, DPM

Foot & Ankle Surgery · Mount Prospect, ILNPI 1942208558

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,216,231 of the $2,245,843 with a category attached, or 98.7%. Treace Medical Concepts, Inc. accounts for 64.4% of it on its own, with 17 other manufacturers making up the rest. Among foot & ankle surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,245,843in general payments, 2019–2025

Across 159 payments — averaging $14,125 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Treace Medical Concepts, Inc.$1.4M
Arthrex$629K
Stryker$142K
Ossio Inc$14K
Novastep Inc.$12K
Smith+Nephew$1K
plus $2K from 12 others

$128,482in research payments, 2019–2025

Across 12 payments — averaging $10,707 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Ipsen Innovation$128K

What the payments were for

Royalty or licence$2,216,23199%
Consulting fees$15,0131%
Speaking & faculty fees$1,4750%
Grants$10,0000%
Travel & lodging$4030%
Food & beverage$2,7220%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Treace Medical Concepts, Inc.	64	$1,445,363
Arthrex	28	$629,337
Stryker	31	$141,922
Ossio Inc	3	$14,191
Novastep Inc.	10	$11,787
Smith+Nephew	1	$1,475
Medline Industries LP	3	$351
Royal Biologics, Inc.	2	$241
Abbott	3	$224
Philips North America LLC	2	$204
Alafair Biosciences, Inc.	2	$177
GLW, Inc	1	$172
Bioventus LLC	1	$111
Organogenesis Inc.	1	$93
Orthofix Medical, Inc.	2	$67
Amgen	2	$61
Melinta Therapeutics, LLC	2	$45
Cordis US CORP.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Lapiplasty System$1,177,925
ARTHREX$944,930
AR-8690S$272,985
LAPIPLASTY SYSTEM 1$267,391
DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS PLANTAR PLATE$162,140
ANCHORAGE$136,380
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE PLANTAR PLATE$135,230
DISTAL EXTREMITIES IMPLANTS FOREFOOT PLANTAR PLATE$58,769
DISTAL EXTREMITIES INSTRUMENTS SOFT TISSUE PLANTAR PLATE$31,860
NEXFIX$5,324
Oasis$1,475
PECA Bunion Correction System$1,327
Fibrinet$175
MaxxCell$175
APOLLO ANKLE$172
Lasers$115
VersaWrap$114
VARIAX$111
Exogen Ultrasound Bone Healing System$111
CREED Ortholocent Implants$110

How this compares

$2,245,843 in reported general payments places this provider in the 95th percentile of 555 foot & ankle surgery providers in Illinois.

See all foot & ankle surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$100,938

Medicare patients

227

Services billed

1,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	28	$1,782
Naproxen	108	$595
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	37	$337
Meloxicam	78	$302
Gabapentin	14	$78

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Mount Prospect

Douglas PacaccioRockford$4.1M
Anand VoraLibertyville$3.2M
Matthew SorensenAlgonquin$1.1M
Edgardo Rodriguez CollazoChicago$755K
David GarrasOrland Park$658K
Patrick McEneaneyCary$570K
Brian BurgessNaperville$488K
Kyle PearsonMorris$208K
Stephanie OexemanChicago$206K
Narendra PatelSchaumburg$180K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →